Conditions: Esophageal Cancer
Intervention Type: Drug
Intervention Name: Akt inhibitor MK2206
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "Akt inhibitor MK2206" on "Esophageal Cancer".
-
A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer
NCTID: NCT01260701
